Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 805-902-5 | 4-amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione | 19171-19-8 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Repr. 1B | H360FD (H360FD:May dama...) | H360FD (May damage fert...) |
GHS08 Dgr |
28 | View details | ||||||
| STOT RE 2 | H373 (other:No specif...) | H373 (May cause damag...) | |||||||||
| Repr. 2 | H361 | H361 |
GHS08 Wng |
3 | View details | ||||||
| Repr. 1B | H360 | H360 |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
| Repr. 2 | H361 (dermal,inhalati...) (Suspected of da...) | H361 |
GHS08 Wng |
State/Form
|
1 | View details | |||||
| Repr. 1B | H360 ((DF)) |
GHS08 Dgr |
State/Form
|
1 | View details | ||||||
| H360Df | |||||||||||
| STOT RE 2 | H373 (other:May cause...) (oral) | H373 | |||||||||
| Repr. 1B | H360 (H360Df May dama...) |
GHS08 Dgr |
State/Form
|
1 | View details | ||||||
| H360Df | |||||||||||
| STOT RE 2 | H373 (lymph node,bloo...) | H373 (Blood, Lymph) | |||||||||
| Acute Tox. 3 | H301 | H301 |
GHS07 GHS08 GHS06 Dgr |
State/Form
|
1 | View details | |||||
| Acute Tox. 4 | H312 | H312 | |||||||||
Number of Aggregated Notifications: 7